DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Feyerabend S. et al.
Indirect Comparison of Abiraterone Acetate and Docetaxel for Treatment of Metastatic Hormone-Sensitive Prostate Cancer.
ESMO 2017;
28 (Suppl. 05) Abstr. 803P
DOI: 10.1093/annonc/mdx370.020.
We do not assume any responsibility for the contents of the web pages of other providers.